Impact ledger
Elicio Therapeutics, Inc. (ELTX)
12 events mapped to this ticker since 2026-06-15.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-06-15 | share_count | Bullish | — | 0.70 |
| 2026-06-15 | net_debt | Bullish | — | 0.70 |
| 2026-06-15 | revenue | Bullish | — | 0.70 |
| 2026-06-15 | net_debt | Bearish | — | 0.70 |
| 2026-06-15 | interest_expense | Bearish | — | 0.70 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-30 | Event | Increased institutional ownership and liquidity due to inclusion in Russell indexes. This can lead to higher trading volumes and potentially a re-rating as more funds are mandated to hold index constituents. | Bullish | 1-3m | 0.70 |
| 2026-06-29 | Event | Increased institutional demand and visibility due to inclusion in Russell 2000/3000 indices. Passive fund inflows. | Bullish | 1-3m | 0.65 |
| 2026-06-17 | Event | Direct impact on corporate structure, financial obligations, and strategic direction. | watch | 1-3m | 0.90 |
| 2026-06-17 | Event | Direct clinical trial success, increasing probability of regulatory approval and commercialization. | Bullish | 1-3m | 0.90 |
| 2026-06-17 | Event | Direct clinical trial success leading to increased investor confidence and potential for future funding/partnerships. | Bullish | 1-3m | 0.90 |
| 2026-06-17 | Event | Regulatory filing disclosure of potentially material information. The 'Other Events' category often signals significant, but not yet fully defined, corporate actions or developments. | watch | 1-5d | 0.60 |
| 2026-06-15 | Event | Market speculation regarding the nature of the 'material definitive agreement' (e.g., acquisition, significant partnership, financing round) will drive immediate share price volatility. | watch | 1-5d | 0.80 |
| 2026-06-15 | Event | Direct impact of failed clinical trial on product viability and immediate need for financing, leading to potential dilution or unfavorable terms. | Bearish | 1-3m | 0.90 |
| 2026-06-15 | Event | Direct impact from material definitive agreement or acquisition announcement. The nature of the agreement (e.g., merger, acquisition, significant partnership, financing) will determine the specific financial implications. | watch | 1-5d | 0.80 |
| 2026-06-15 | Event | Clinical trial failure leading to uncertainty in future development and funding. | Bearish | 1-3m | 0.90 |
| 2026-06-15 | Event | Clinical trial failure, increased financing risk, potential for dilutive financing or strategic alternatives. | Bearish | 1-3m | 0.90 |
| 2026-06-15 | Event | Direct clinical trial failure leading to uncertainty about future product development and financing. This directly impacts the company's primary asset. | Bearish | 1-3m | 0.90 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for ELTX, start a trial or view the ELTX entity page.